000 01161 a2200313 4500
005 20250518090653.0
264 0 _c20210624
008 202106s 0 0 eng d
022 _a1460-2091
024 7 _a10.1093/jac/dkaa067
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeegwater, E
245 0 0 _aPopulation pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_c06 2020
300 _a1554-1558 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aCeftriaxone
650 0 4 _aCritical Illness
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMonte Carlo Method
700 1 _aKraaijenbrink, B V C
700 1 _aMoes, D J A R
700 1 _aPurmer, I M
700 1 _aWilms, E B
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 75
_gno. 6
_gp. 1554-1558
856 4 0 _uhttps://doi.org/10.1093/jac/dkaa067
_zAvailable from publisher's website
999 _c30703363
_d30703363